Proteomic analysis identifies differentially expressed proteins in AML1/ETO acute myeloid leukemia cells treated with DNMT inhibitors azacitidine and decitabine-Reference-Cited by-同舟云学术

Proteomic analysis identifies differentially expressed proteins in AML1/ETO acute myeloid leukemia cells treated with DNMT inhibitors azacitidine and decitabine

Published:2012-05 Issue:5 Volume:36 Page:607-618
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Buchi Francesca,Spinelli Elena,Masala Erico,Gozzini Antonella,Sanna Alessandro,Bosi Alberto,Ferrari Germano,Santini Valeria

Funder

Regione Toscana, Bando Salute 2009

Ente Cassa di Risparmio di Firenze (ECR)

Ministero per l’Istruzione, l’Università e la Ricerca (MIUR)

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference30 articles.

1. Changes in DNA methylation in neoplasia: pathophysiology and therapeutic implications;Santini;Ann Intern Med,2001

2. Azacitidine: activity and efficacy as an epigenetic treatment of myelodysplastic syndromes;Santini;Expert Rev Hematol,2009

3. A comparison of azacitidine and decitabine activities in acute myeloid leukemia cell lines;Hollenbach;PLoS One,2010

4. Cytotoxicity and mode of action of 5-azacytidine on L1210 leukemia;Li;Cancer Res,1970

5. Equitoxic doses of 5-azacytidine and 5-aza-2′deoxycytidine induce diverse immediate and overlapping heritable changes in the transcriptome;Qiu;PLoS One,2010

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fetal hemoglobin level predicts lower-risk myelodysplastic syndrome;International Journal of Hematology;2022-12-27

2. Mass Spectrometry: A Powerful Method for Monitoring Various Type of Leukemia, Especially MALDI-TOF in Leukemia’s Proteomics Studies Review;Critical Reviews in Analytical Chemistry;2021-01-26

3. Acute myeloid leukemia arising after Hodgkin lymphoma in a patient with WHIM syndrome;Pediatric Blood & Cancer;2019-07-31

4. Enhanced anticancer effects of a methylation inhibitor by inhibiting a novel DNMT1 target, CEP 131, in cervical cancer;BMB Reports;2019-05-31

5. Proteomics in Acute Myeloid Leukemia;Myeloid Leukemia;2018-05-16